Kidney Disease-Associated APOL1 Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function.
暂无分享,去创建一个
M. Pollak | Opeyemi A. Olabisi | Jia-yue Zhang | N. Zahler | Somenath Datta | Rama Kataria | Savannah Moore | K. Petitpas | A. Mohamed.
暂无分享,去创建一个
M. Pollak | Opeyemi A. Olabisi | Jia-yue Zhang | N. Zahler | Somenath Datta | Rama Kataria | Savannah Moore | K. Petitpas | A. Mohamed.